File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

TitlePeptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
Authors
Xia, SChan, JFWWang, LJiao, FChik, KKHChu, HLan, QXu, WWang, QWang, CYuen, KYLu, LJiang, S
Issue Date2022
Citation
Cell Research, 2022, v. 32, p. 404-406 How to Cite?
DOI: http://dx.doi.org/10.1038/s41422-022-00617-x
Persistent Identifierhttp://hdl.handle.net/10722/319256
ISI Accession Number ID
WOS:000749070700001

 

DC FieldValueLanguage
dc.contributor.authorXia, S-
dc.contributor.authorChan, JFW-
dc.contributor.authorWang, L-
dc.contributor.authorJiao, F-
dc.contributor.authorChik, KKH-
dc.contributor.authorChu, H-
dc.contributor.authorLan, Q-
dc.contributor.authorXu, W-
dc.contributor.authorWang, Q-
dc.contributor.authorWang, C-
dc.contributor.authorYuen, KY-
dc.contributor.authorLu, L-
dc.contributor.authorJiang, S-
dc.date.accessioned2022-10-14T05:10:00Z-
dc.date.available2022-10-14T05:10:00Z-
dc.date.issued2022-
dc.identifier.citationCell Research, 2022, v. 32, p. 404-406-
dc.identifier.urihttp://hdl.handle.net/10722/319256-
dc.languageeng-
dc.relation.ispartofCell Research-
dc.titlePeptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant-
dc.typeArticle-
dc.identifier.emailChan, JFW: jfwchan@hku.hk-
dc.identifier.emailChik, KKH: kennchik@HKUCC-COM.hku.hk-
dc.identifier.emailChu, H: hinchu@hku.hk-
dc.identifier.emailYuen, KY: kyyuen@hkucc.hku.hk-
dc.identifier.authorityChan, JFW=rp01736-
dc.identifier.authorityChu, H=rp02125-
dc.identifier.authorityYuen, KY=rp00366-
dc.identifier.doi10.1038/s41422-022-00617-x-
dc.identifier.hkuros338602-
dc.identifier.volume32-
dc.identifier.spage404-
dc.identifier.epage406-
dc.identifier.isiWOS:000749070700001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats